We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
-2.36%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$46.8B
AUM Growth
-$2.48B
Cap. Flow
-$831M
Cap. Flow %
-1.77%
Top 10 Hldgs %
28.11%
Holding
1,786
New
25
Increased
394
Reduced
504
Closed
30

Top Buys

Rank Stock Value
1
CCI icon
Crown Castle
CCI
+$130M
2
AMGN icon
Amgen
AMGN
+$96.1M
3
PGR icon
Progressive
PGR
+$94.9M
4
ABBV icon
AbbVie
ABBV
+$77.1M
5
KVUE icon
Kenvue
KVUE
+$75.6M

Top Sells

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$148M
2
JNJ icon
Johnson & Johnson
JNJ
+$147M
3
LYB icon
LyondellBasell Industries
LYB
+$108M
4
DG icon
Dollar General
DG
+$91.2M
5
XOM icon
ExxonMobil
XOM
+$87.6M

Sector Composition

Rank Sector Weight
1 Technology 24.48%
2 Healthcare 17.42%
3 Financials 12.53%
4 Consumer Discretionary 9.71%
5 Communication Services 7.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BWIN
1501
Baldwin Insurance Group
BWIN
$2.67B
$638K ﹤0.01%
27,470
IMKTA icon
1502
Ingles Markets
IMKTA
$1.67B
$636K ﹤0.01%
8,440
LLYVK icon
1503
Liberty Live Group Series C
LLYVK
$9.41B
$634K ﹤0.01%
+19,738
New +$654K
EVTC icon
1504
Evertec
EVTC
$1.88B
$634K ﹤0.01%
17,040
DMC
1505
Del Monte Corp
DMC
$1.36B
$633K ﹤0.01%
24,500
DIN icon
1506
Dine Brands
DIN
$448M
$632K ﹤0.01%
12,777
AMBA icon
1507
Ambarella
AMBA
$2.99B
$629K ﹤0.01%
11,860
NTST
1508
NETSTREIT Corp
NTST
$2.13B
$629K ﹤0.01%
40,360
NRIX icon
1509
Nurix Therapeutics
NRIX
$2.43B
$628K ﹤0.01%
79,907
TRIP icon
1510
TripAdvisor
TRIP
$1.66B
$627K ﹤0.01%
37,840
HTZ icon
1511
Hertz
HTZ
$632M
$627K ﹤0.01%
51,210
PSN icon
1512
Parsons
PSN
$6.36B
$625K ﹤0.01%
11,500
OUT icon
1513
Outfront Media
OUT
$5.68B
$625K ﹤0.01%
62,848
AMKR icon
1514
Amkor Technology
AMKR
$15B
$624K ﹤0.01%
27,590
LMAT icon
1515
LeMaitre Vascular
LMAT
$2.26B
$621K ﹤0.01%
11,400
CSGS
1516
DELISTED
CSG Systems International
CSGS
$621K ﹤0.01%
12,143
FBNC icon
1517
First Bancorp
FBNC
$2.59B
$620K ﹤0.01%
22,020
CBAY
1518
DELISTED
Cymabay Therapeutics
CBAY
$615K ﹤0.01%
+41,250
New +$547K
SCL icon
1519
Stepan Co
SCL
$1.31B
$614K ﹤0.01%
8,196
CPE
1520
DELISTED
Callon Petroleum Company
CPE
$613K ﹤0.01%
15,670
RPT
1521
DELISTED
RPT Realty Common Shares of Beneficial Interest (MD)
RPT
$611K ﹤0.01%
57,900
VBTX
1522
DELISTED
Veritex Holdings
VBTX
$611K ﹤0.01%
34,030
CTS icon
1523
CTS Corp
CTS
$1.73B
$609K ﹤0.01%
14,600
ELDN icon
1524
Eledon Pharmaceuticals
ELDN
$276M
$607K ﹤0.01%
443,001
NGVT icon
1525
Ingevity
NGVT
$2.59B
$607K ﹤0.01%
12,745

Similar funds

Ensign Peak Advisors's Q3 2023 Portfolio in Review

As of Q3 2023, Ensign Peak Advisors held 1,786 positions worth $46.8B, down 5% from $49.3B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Trading was light in Q3 2023: portfolio turnover was 3.1%. Ensign Peak Advisors opened 25 new positions and exited 30, leaving the 1,786-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

  • Ensign Peak Advisors's largest Q3 2023 buy was Invesco QQQ Trust: 160,000 shares worth $57.3M.
  • Ensign Peak Advisors added most to Crown Castle in Q3 2023, an estimated $130M increase.
  • Ensign Peak Advisors's biggest Q3 2023 reduction was Eli Lilly, cutting an estimated $148M.
  • Ensign Peak Advisors fully exited RB Global in Q3 2023, selling an estimated $26.5M.
  • Ensign Peak Advisors's ten largest holdings make up 28% of its $46.8B portfolio in Q3 2023.
  • Ensign Peak Advisors opened 25 new positions and closed 30 in Q3 2023.
  • Ensign Peak Advisors's portfolio value fell 5% quarter-over-quarter to $46.8B.

Based on Ensign Peak Advisors's 13F filing for Q3 2023, filed 13 Nov 2023.